Publicacións en colaboración con investigadores/as de Hospital Universitario de Jaén (22)

2022

  1. Process of medical nutrition therapy

    Nutricion Hospitalaria, Vol. 39, Núm. 5, pp. 1166-1189

  2. Registro del Grupo NADYA-SENPE de Nutrición Enteral Domiciliaria en España: años 2018 y 2019

    Nutricion hospitalaria, Vol. 39, Núm. 1, pp. 223-229

2021

  1. Real-life use of ramucirumab in gastric cancer in Spain: The RAMIS study

    Future Oncology, Vol. 17, Núm. 14, pp. 1777-1791

2020

  1. Home and Ambulatory Artificial Nutrition (NADYA) group report. Home parenteral nutrition in Spain, 2018

    Nutricion Hospitalaria, Vol. 37, Núm. 2, pp. 403-407

2019

  1. Safety and efficacy of bosutinib in fourth-line therapy of chronic myeloid leukemia patients

    Annals of Hematology, Vol. 98, Núm. 2, pp. 321-330

  2. Spanish home enteral nutrition registry of the year 2016 and 2017 from the NADYA-SENPE Group

    Nutricion Hospitalaria, Vol. 36, Núm. 1, pp. 233-237

2018

  1. Home and ambulatory artificial nutrition (NADYA) report. home parenteral nutrition in Spain, 2017

    Nutricion Hospitalaria, Vol. 35, Núm. 6, pp. 1491-1496

2017

  1. Nutrición parenteral domiciliaria en españa 2016; informe del grupo de nutrición artificial domiciliaria y ambulatoria nadya

    Nutricion Hospitalaria, Vol. 34, Núm. 6, pp. 1497-1501

  2. Registro del Grupo NADYA-SENPE de nutrición enteral domiciliaria en España, años 2014 y 2015

    Nutricion Hospitalaria, Vol. 34, Núm. 1, pp. 15-18

2016

  1. An assessment of the management of spasticity in Spain: The 5E study

    Revista de Neurologia, Vol. 63, Núm. 7, pp. 289-296

  2. Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study

    BMC Cancer, Vol. 16, Núm. 1

  3. Potential risk for inappropriate dyslipidemia screening in Primary Care in Spain

    Revista del Laboratorio Clinico, Vol. 9, Núm. 2, pp. 48-53

  4. Request of thyroid function tests from Primary Care in Spain

    Endocrinologia y Nutricion, Vol. 63, Núm. 1, pp. 19-26

2015

  1. Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program

    American Journal of Hematology, Vol. 90, Núm. 5, pp. 429-433

  2. Encuesta nacional sobre los temores del paciente ante una intervención de cirugía general

    Cirugia Espanola, Vol. 93, Núm. 10, pp. 643-650

2014

  1. A study of the differences in the request of glycated hemoglobin in primary care in Spain: A global, significant, and potentially dangerous under-request

    Clinical Biochemistry, Vol. 47, Núm. 12, pp. 1104-1107

  2. Variation in laboratory tests ordered for patients treated in hospital emergency departments

    Emergencias, Vol. 26, Núm. 6, pp. 450-458

2008

  1. Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres

    Diabetic Medicine, Vol. 25, Núm. 4, pp. 427-434

  2. Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903

    Clinical Infectious Diseases, Vol. 47, Núm. 8, pp. 1083-1092

  3. Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens

    HIV Clinical Trials, Vol. 9, Núm. 5, pp. 309-313